Evidence map›Paper›PMID 34115919›Full record

ArticleChemMedChem2021

Functionalized Cyclopentenones and an Oxime Ether as Antimicrobial Agents.

Rafael F A Gomes, Vera M S Isca, Késsia Andrade, Patrícia Rijo, Carlos A M Afonso

Abstract read
In one paragraph

Article in ChemMedChem, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rafael F A GomesResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003, Lisboa, Portugal.ORCID 0000-0002-2598-8540
Vera M S IscaResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003, Lisboa, Portugal.
Késsia AndradeResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003, Lisboa, Portugal.
Patrícia RijoResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003, Lisboa, Portugal.
Carlos A M AfonsoResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003, Lisboa, Portugal.

Funding

COMPETE Programme SAICTPAC/0019/2015European Union's Horizon 2020 research and innovation programme 951996Fundação para a Ciência e a Tecnologia PTDC/QUI-QOR/32008/2017Fundação para a Ciência e a Tecnologia SFRH/BD/137671/2018Fundação para a Ciência e a Tecnologia SFRH/BD/148211/2019Fundação para a Ciência e a Tecnologia UIDB/04567/2020Fundação para a Ciência e a Tecnologia UID/DTP/04138/2019Fundação para a Ciência e a Tecnologia UIDP/04567/2020
6 · The paper itself

Abstract

Several naturally occurring cyclopentenones, such as palmenones and nigrosporiones, exhibit antimicrobial activity. Herein we describe the antimicrobial activity of cyclopentenones and derivatives that can be easily accessed from biomass derivatives furfural and 5-hydroxymethylfurfural. Upon screening a range of functionalized trans-diamino-cyclopentenones (DCPs) and δ-lactone-fused cyclopentenones (LCPs), an oxime ether derivative of DCP was identified that exhibited remarkable antimicrobial activity against Gram-positive bacteria, including resistant strains such as methicillin-resistant S. aureus (MRSA) and vancomycin-resistant E. faecalis (VRE) strains.

Indexed as

Anti-Bacterial AgentsCyclopentanesDose-Response Relationship, DrugEnterococcus faecalisEtherMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsMolecular StructureOximesStructure-Activity RelationshipVancomycin ResistanceAnti-Bacterial AgentsCyclopentanescyclopentenoneEtherOximesantimicrobialbiomasscyclopentenonesfurfuralssustainability

Identifiers

PMID34115919
PMCPMC8518054

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.